Morgan Stanley’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.9M | Buy |
824,819
+85,134
| +12% | +$349K | ﹤0.01% | 4494 |
|
|
2025
Q4 | $2.49M | Buy |
739,685
+262,585
| +55% | +$682K | ﹤0.01% | 4657 |
|
|
2025
Q3 | $625K | Sell |
477,100
-16,934
| -3% | -$17.5K | ﹤0.01% | 5413 |
|
|
2025
Q2 | $354K | Sell |
494,034
-1,369,187
| -73% | -$1.07M | ﹤0.01% | 5622 |
|
|
2025
Q1 | $2.74M | Sell |
1,863,221
-2,161,472
| -54% | -$5.15M | ﹤0.01% | 4410 |
|
|
2024
Q4 | $17.8M | Sell |
4,024,693
-296,896
| -7% | -$1.2M | ﹤0.01% | 2869 |
|
|
2024
Q3 | $17.8M | Sell |
4,321,589
-539,239
| -11% | -$2.9M | ﹤0.01% | 2908 |
|
|
2024
Q2 | $31.7M | Buy |
4,860,828
+2,182,712
| +82% | +$15.4M | ﹤0.01% | 2177 |
|
|
2024
Q1 | $23.3M | Sell |
2,678,116
-1,617,520
| -38% | -$19.6M | ﹤0.01% | 2529 |
|
|
2023
Q4 | $49.1M | Buy |
4,295,636
+2,394,853
| +126% | +$23.7M | ﹤0.01% | 2476 |
|
|
2023
Q3 | $18.3M | Sell |
1,900,783
-1,167,556
| -38% | -$11.4M | ﹤0.01% | 2544 |
|
|
2023
Q2 | $32.6M | Sell |
3,068,339
-730,654
| -19% | -$7.85M | ﹤0.01% | 1976 |
|
|
2023
Q1 | $40M | Buy |
3,798,993
+1,140,486
| +43% | +$12.8M | ﹤0.01% | 1754 |
|
|
2022
Q4 | $32.9M | Buy |
2,658,507
+455,105
| +21% | +$5.16M | ﹤0.01% | 1875 |
|
|
2022
Q3 | $22.8M | Sell |
2,203,402
-374,129
| -15% | -$4.24M | ﹤0.01% | 2052 |
|
|
2022
Q2 | $29.7M | Buy |
2,577,531
+293,707
| +13% | +$3.46M | ﹤0.01% | 1858 |
|
|
2022
Q1 | $28.7M | Buy |
2,283,824
+1,230,402
| +117% | +$14.1M | ﹤0.01% | 1746 |
|
|
2021
Q4 | $12.3M | Sell |
1,053,422
-654,367
| -38% | -$8.03M | ﹤0.01% | 2709 |
|
|
2021
Q3 | $22.3M | Buy |
1,707,789
+253,636
| +17% | +$3.28M | ﹤0.01% | 1978 |
|
|
2021
Q2 | $18.7M | Buy |
1,454,153
+449,360
| +45% | +$5.14M | ﹤0.01% | 2231 |
|
|
2021
Q1 | $11.2M | Sell |
1,004,793
-263,728
| -21% | -$2.79M | ﹤0.01% | 2527 |
|
|
2020
Q4 | $14.4M | Buy |
1,268,521
+373,810
| +42% | +$4.09M | ﹤0.01% | 2128 |
|
|
2020
Q3 | $8.05M | Buy |
894,711
+770,078
| +618% | +$7.65M | ﹤0.01% | 2229 |
|
|
2020
Q2 | $1.29M | Buy |
124,633
+74,294
| +148% | +$760K | ﹤0.01% | 3975 |
|
|
2020
Q1 | $508K | Sell |
50,339
-252,721
| -83% | -$2.97M | ﹤0.01% | 4356 |
|
|
2019
Q4 | $4.03M | Buy |
303,060
+181,465
| +149% | +$2M | ﹤0.01% | 3432 |
|
|
2019
Q3 | $1.04M | Buy |
121,595
+31,302
| +35% | +$304K | ﹤0.01% | 4275 |
|
|
2019
Q2 | $988K | Sell |
90,293
-380,542
| -81% | -$4.26M | ﹤0.01% | 4230 |
|
|
2019
Q1 | $5.33M | Sell |
470,835
-409,296
| -47% | -$4.57M | ﹤0.01% | 2640 |
|
|
2018
Q4 | $7.64M | Buy |
880,131
+572,547
| +186% | +$6.57M | ﹤0.01% | 2411 |
|
|
2018
Q3 | $4.75M | Sell |
307,584
-123,493
| -29% | -$1.95M | ﹤0.01% | 3236 |
|
|
2018
Q2 | $6.9M | Buy |
431,077
+28,287
| +7% | +$419K | ﹤0.01% | 2782 |
|
|
2018
Q1 | $5.21M | Buy |
402,790
+28,119
| +8% | +$350K | ﹤0.01% | 2989 |
|
|
2017
Q4 | $4.7M | Buy |
374,671
+88,940
| +31% | +$1.16M | ﹤0.01% | 3173 |
|
|
2017
Q3 | $3.77M | Buy |
285,731
+69,686
| +32% | +$959K | ﹤0.01% | 3271 |
|
|
2017
Q2 | $3.42M | Sell |
216,045
-43,325
| -17% | -$630K | ﹤0.01% | 3289 |
|
|
2017
Q1 | $3.71M | Sell |
259,370
-313,010
| -55% | -$4.28M | ﹤0.01% | 3192 |
|
|
2016
Q4 | $7.33M | Buy |
572,380
+387,724
| +210% | +$4.9M | ﹤0.01% | 2594 |
|
|
2016
Q3 | $2.46M | Sell |
184,656
-20,230
| -10% | -$236K | ﹤0.01% | 3319 |
|
|
2016
Q2 | $2.24M | Sell |
204,886
-373,269
| -65% | -$3.65M | ﹤0.01% | 3332 |
|
|
2016
Q1 | $5.3M | Sell |
578,155
-572,648
| -50% | -$4.72M | ﹤0.01% | 2471 |
|
|
2015
Q4 | $11.2M | Sell |
1,150,803
-59,345
| -5% | -$574K | ﹤0.01% | 1882 |
|
|
2015
Q3 | $10.6M | Sell |
1,210,148
-6,328,354
| -84% | -$59M | ﹤0.01% | 1901 |
|
|
2015
Q2 | $76.1M | Sell |
7,538,502
-1,033,748
| -12% | -$12M | 0.03% | 636 |
|
|
2015
Q1 | $115M | Sell |
8,572,250
-653,503
| -7% | -$8.57M | 0.04% | 456 |
|
|
2014
Q4 | $118M | Sell |
9,225,753
-391,042
| -4% | -$4.48M | 0.04% | 453 |
|
|
2014
Q3 | $104M | Sell |
9,616,795
-35,644
| -0.4% | -$408K | 0.04% | 500 |
|
|
2014
Q2 | $124M | Sell |
9,652,439
-53,605
| -0.6% | -$583K | 0.05% | 432 |
|
|
2014
Q1 | $100M | Sell |
9,706,044
-298,440
| -3% | -$3.36M | 0.04% | 475 |
|
|
2013
Q4 | $97.3M | Sell |
10,004,484
-1,377,327
| -12% | -$12.4M | 0.04% | 465 |
|
|
2013
Q3 | $113M | Sell |
11,381,811
-224,119
| -2% | -$2.2M | 0.05% | 378 |
|
|
2013
Q2 | $96.5M | Buy |
+11,605,930
| New | +$141M | 0.05% | 417 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Morgan Stanley's IRWD Position: Q1 2026 in Review
Morgan Stanley increased its Ironwood Pharmaceuticals (IRWD) stake by 12% in Q1 2026, buying an estimated $349K and bringing the position to 824,819 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #4494.
Morgan Stanley first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $124M in Q2 2014. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Morgan Stanley held 824,819 shares of Ironwood Pharmaceuticals worth $2.9M as of Q1 2026.
- Morgan Stanley bought 85,134 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $349K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4494 holding.
- Morgan Stanley first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Ironwood Pharmaceuticals position peaked at $124M in Q2 2014.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.